ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Recruiting

Back to Major Depressive Disorder trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Laureate Institute for Brain Research, Tulsa, Oklahoma

Key details

Phase

Early testing / Safety & dosing

Sponsor

Laureate Institute for Brain Research, Inc.

Enrollment target

~24 participants

Started

November 2021

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov

ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION — Stella